Proclaiming November 2023 to be Diabetes Awareness Month in Wisconsin.
By recognizing November 2023 as Diabetes Awareness Month, SJR89 aims to promote education regarding diabetes management and prevention. The resolution points out that diabetes is one of the leading causes of death in the United States and signifies the urgent need for comprehensive strategies to counter its prevalence. Through increased awareness, the legislation could foster a better understanding amongst the public and healthcare providers, potentially leading to improved health outcomes for those living with diabetes. It encourages initiatives that focus on early detection, proper treatment, and the necessity of ongoing research into diabetes control.
Senate Joint Resolution 89 (SJR89) seeks to officially proclaim November 2023 as Diabetes Awareness Month in Wisconsin. This resolution aligns Wisconsin's awareness efforts with national campaigns led by organizations such as the Juvenile Diabetes Research Foundation and the American Diabetes Association. The resolution emphasizes the importance of raising awareness about diabetes as a chronic disease that affects a substantial number of residents in Wisconsin, highlighting that over 541,000 individuals are currently living with the disease in the state. The resolution articulates the need for increased public knowledge regarding the types of diabetes, symptoms, and the complications resulting from poor glucose management.
Although the resolution is largely symbolic, there are aspects of broader concern related to diabetes management highlighted in the discussions surrounding SJR89. The bill points to issues such as the rising costs of insulin and diabetes-monitoring equipment, which pose significant barriers for individuals needing these essential supplies. Critically, it addresses the insulin pricing crisis that is causing individuals to ration their insulin, thereby increasing health risks and complications. The resolution's recognition could serve as a platform for future conversations around healthcare access and the financial burden faced by individuals with diabetes.